Aptevo Therapeutics (APVO) Gross Profit Growth (1y) (2016 - 2019)
Aptevo Therapeutics (APVO) Gross Profit Growth (1y) (2016 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 126.09% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 33.01% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 57.16% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -99.98% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 351.57% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -49.32% |
| Jun 30, 2019 | -79.11% |
| Mar 31, 2019 | 38.65% |
| Sep 30, 2018 | 131.84% |
| Jun 30, 2018 | 377.60% |
| Mar 31, 2018 | 38.45% |
| Sep 30, 2017 | 432.30% |
| Jun 30, 2017 | -165.59% |
| Mar 31, 2017 | -63.56% |
| Dec 31, 2016 | 20.99% |
| Sep 30, 2016 | -142.61% |
| Jun 30, 2016 | 36.36% |